The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 19,901–20,000 of 31,469
Kojima, M., Dohi, Y., Ohashi, M., Sato, K., & Kimura, G. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833d025b · Cited by 11
Insulin resistance is not necessarily an essential element of metabolic syndrome
Karnchanasorn, R., Ou, H.-Y., Chuang, L., & Chiu, K. C. (2012) · Endocrine · doi:10.1007/s12020-012-9702-3 · Cited by 12
Forrester, J., McGovern, B., Rhee, M., & Sterling, R. (2009) · HIV Medicine · doi:10.1111/j.1468-1293.2009.00722.x · Cited by 11
Derosa, G., Cicero, A. F. G., Carbone, A., Querci, F., Fogari, E., D’Angelo, A., & Maffioli, P. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.031 · Cited by 11
RetractedFu, C.-P., Lee, I., Sheu, W., Lee, W.-J., Liang, K.-W., Lee, W.-L., & Lin, S.-Y. (2012) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/j.cca.2012.05.008 · Cited by 11
Vyssoulis, G. P., Karpanou, E., Adamopoulos, D. N., Tzamou, V., Stefanadis, C., & Vischer, U. M. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.035 · Cited by 11
Slavin, B. G., Zarow, C., Warden, C. H., & Fisler, J. S. (2009) · The Anatomical Record · doi:10.1002/ar.21019 · Cited by 11
Saki, F., Ashkani‐Esfahani, S., & Karamizadeh, Z. (2013) · Europe PMC (PubMed Central) · Cited by 11
Caligiuri, S. P. B., Blydt‐Hansen, T. D., Love, K., Grégoire, M., Taylor, C. G., Zahradka, P. C., & Aukema, H. M. (2014) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2013-0476 · Cited by 11
Goto, M., Morita, A., Goto, A., Sasaki, S., Aiba, N., Shimbo, T., Terauchi, Y., Miyachi, M., Noda, M., & Watanabe, S. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-79 · Cited by 13
GIPR Gene Polymorphism and Weight Gain in Patients With Schizophrenia Treated With Olanzapine
Ono, S., Suzuki, Y., Fukui, N., Sawamura, K., Sugai, T., Watanabe, J., Tsuneyama, N., & Someya, T. (2014) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.13120389 · Cited by 11
McGee, K. C., Shahmanesh, M., Boothby, M., Nightingale, P., Gathercole, L., Tripathi, G., Harte, A. L., Shojaee‐Moradie, F., Umpleby, A. M., Das, S., et al. (2011) · Antiviral Therapy · doi:10.3851/imp2017 · Cited by 11
Nar, A., Demirtaş, E., Ayhan, A., & Gürlek, A. (2009) · Gynecological Endocrinology · doi:10.3109/09513590903159532 · Cited by 11
Liao, S., Liu, Y., Chen, X., Tan, Y.-D., Mei, J., Song, W., Gan, L., Wang, H., Yin, S., Dong, X., et al. (2015) · Reproductive Sciences · doi:10.1177/1933719115580995 · Cited by 11
Ding, P. Y., Hsu, P., & Lu, T. (2009) · Cited by 11
Daylong triglyceridaemia in healthy Mediterranean and northern European subjects.
van Oostrom, A. J. H. H. M., Jt, R., Carmena, R., Ascaso, J. F., & Castro Cabezas, M. (2004) · PubMed · Cited by 11
de Oliveira, A., Hermsdorff, H. H. M., Cocate, P. G., dos Santos, E. C., Bressan, J., & Natali, A. J. (2015) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2014-0487 · Cited by 11
Prasad, N. R., Reddy, P., Kumar, K., & Vyshnavi, K. (2015) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-015-0448-3 · Cited by 11
Nanditha, A., Snehalatha, C., Ram, J., Selvam, S., Vijaya, L., Shetty, S., Arun, R., & Ramachandran, A. (2016) · Diabetic Medicine · doi:10.1111/dme.13071 · Cited by 10
Lindsey, J. C., Jacobson, D. L., Li, H., et al. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31823fdbec · Cited by 11
Teich, T., Dunford, E. C., Porras, D. P., Pivovarov, J. A., Beaudry, J. L., Hunt, H., Belanoff, J. K., & Riddell, M. C. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00490.2015 · Cited by 10
Anthropometric index for insulin sensitivity assessment in older adults from Ecuadorian highlands
Velásquez, J., Severeyn, É., Herrera, H., Encalada, L., & Wong, S. (2017) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2257207 · Cited by 11
Increased circulating full-length betatrophin levels in drug-naïve metabolic syndrome
Liu, D., Li, S., He, H., Yu, C., Li, X., Liang, L., Chen, Y., Li, J., Li, J., Sun, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15102 · Cited by 11
Gül, Ö. Ö., Cander, S., Gul, C. B., et al. (2017) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2017.1309011 · Cited by 11
Ryan, A. S., Serra, M. C., & Goldberg, A. P. (2017) · Obesity · doi:10.1002/oby.22032 · Cited by 11
Sharifi, M., Ghandi, Y., Habibi, D., et al. (2018) · Annals of Pediatric Cardiology · doi:10.4103/apc.apc_75_17 · Cited by 11
Lalic, K. S., Nedeljkovic, M. A., Jotić, A., Babić, R., Rajkovic, N., Popović, L., Lukić, L., Milicic, T. J., Lukač, S. S., Stošić, L., et al. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.005 · Cited by 11
Dietary Interventions and Type 2 Diabetes in Youth: a Fresh Look at the Evidence
Perkison, W. B., Adekanye, J. A., & Otto, M. C. D. O. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0241-2 · Cited by 11
Zhan, X., Wang, L., Wang, Z., Chai, S., Zhu, X., Ren, W., & Chang, X. (2019) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.18-81 · Cited by 11
Adamska, A., Krentowska, A., Łebkowska, A., Hryniewicka, J., Leśniewska, M., Adamski, M., & Kowalska, I. (2019) · Endocrine · doi:10.1007/s12020-019-01913-0 · Cited by 11
Silva, M. I. B., Klein, M. R. S. T., CARDOSO, E. S., da Costa, M. S., Martins, C. J. D. M., & Bregman, R. (2019) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2019.02.001 · Cited by 11
Forseth, B. M., Boyer, W. R., Miller, A. L., & Fitzhugh, E. C. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.04.006 · Cited by 11
Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice
Bağcı, R., Şahıntürk, V., & Şahin, E. (2019) · Tissue and Cell · doi:10.1016/j.tice.2019.07.001 · Cited by 11
jinkee, P., Park, J., & Park, H. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16162978 · Cited by 11
Pedersen, M., Halldorsson, T. I., Ketzel, M., et al. (2019) · Environmental Epidemiology · doi:10.1097/ee9.0000000000000069 · Cited by 11
de Luis, D. A., Primo, D., Izaola, O., et al. (2019) · Lifestyle Genomics · doi:10.1159/000503863 · Cited by 11
Abulmeaty, M. M. A., Almajwal, A. M., Elsadek, M. F., Berika, M. Y., & Razak, S. (2019) · International Journal of Endocrinology · doi:10.1155/2019/7546385 · Cited by 11
Bi, H., Niu, D., Guo, C., Jia, L., Chen, X., Zhang, Y., Wang, S., Bai, J., Li, X., & Kang, J. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/3986964 · Cited by 11
Raglan, O., Assi, N., Nautiyal, J., et al. (2019) · Translational research · doi:10.1016/j.trsl.2019.12.003 · Cited by 11
Lower eGFR is associated with increased probability of liver fibrosis in Chinese diabetic patients
Wang, Y., Yu, Y., Wan, H., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3294 · Cited by 11
He, X., & Ma, H. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s242657 · Cited by 11
Implications of maraviroc and/or rapamycin in a mouse model of fragility
Pérez‐Martínez, L., Romero, L., Muñoz-Galván, S., Verdugo‐Sivianes, E. M., Rubio-Mediavilla, S., Oteo, J. A., Carnero, A., & Blanco, J. R. (2020) · Aging · doi:10.18632/aging.103167 · Cited by 9
Szczerbiński, Ł., Gościk, J., Bauer, W., Wawrusiewicz‐Kurylonek, N., Paczkowska‐Abdulsalam, M., Niemira, M., Citko, A., Adamska-Patruno, E., Górska, M., & Kretowski, A. J. (2019) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.14866 · Cited by 13
Is Macronutrients Intake a Challenge for Cardiometabolic Risk in Obese Adolescents?
Vizzuso, S., Amatruda, M., Torto, A. D., D’Auria, E., Ippolito, G., Zuccotti, G., & Verduci, E. (2020) · Nutrients · doi:10.3390/nu12061785 · Cited by 11
Obesity May Connect Insulin Resistance to Decreased Neuronal Viability in Human Diabetic Brain
Lee, S. L., Joo, Y., Kim, R. Y., Hwang, J., Lim, S. M., Yoon, S. J., & Kim, J. (2020) · Obesity · doi:10.1002/oby.22869 · Cited by 11
Choi, D., Kim, B., Jung, C., Kim, C., & Mok, J. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0219 · Cited by 19
Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial
Hu, J., Wu, Y., Sacks, F. M., Appel, L. J., Miller, E. R., Young, J. H., & Juraschek, S. P. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001457 · Cited by 11
Aadland, E., Nilsen, A. K. O., Andersen, L. B., et al. (2020) · Journal of Sports Sciences · doi:10.1080/02640414.2020.1824341 · Cited by 11
Alotaibi, T. F., Thackray, A. E., Roberts, M. J., Alanazi, T. M., BISHOP, N. C., Wadley, A. J., King, J. A., O’Donnell, E., STEINER, M. C., Singh, S. J., et al. (2020) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002560 · Cited by 11
Nussbaumer, R., Meyer‐Gerspach, A. C., Peterli, R., Peters, T. T. A., Beglinger, C., Chiappetta, S., Drewe, J., & Wölnerhanssen, B. K. (2020) · Obesity Facts · doi:10.1159/000511928 · Cited by 14
Garcés, M. F., Buell‐Acosta, J. D., Rodríguez‐Navarro, H. A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77961-8 · Cited by 11
University Students with PCOS Demonstrate Limited Nutrition Knowledge
Douglas, C. C., Jones, R., Green, R., Brown, K., Yount, G., & Williams, R. G. (2021) · American Journal of Health Education · doi:10.1080/19325037.2021.1877218 · Cited by 12
Koca, N., Ayar, K., Bal, Ö., & Ersoy, C. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.20.03158-2 · Cited by 11
Reddy, K., & Yadav, S. (2021) · Journal of Postgraduate Medicine · doi:10.4103/jpgm.jpgm_887_20 · Cited by 11
Ishitobi, T., Hyogo, H., Tokumo, H., Arihiro, K., & Chayama, K. (2013) · Hepatology Research · doi:10.1111/hepr.12135 · Cited by 11
Edmonton Obesity Staging System: an improvement by cardiopulmonary exercise testing
Bettini, S., Quinto, G., Neunhäeuserer, D., Battista, F., Belligoli, A., Milan, G., Gasperetti, A., Vettor, R., Ermolao, A., & Busetto, L. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00856-9 · Cited by 12
Ribeiro, P. V. D. M., Machado, A. M., da Silva, N. B. M., de Oliveira, L. L., & Alfenas, R. D. C. G. (2021) · Nutrition · doi:10.1016/j.nut.2021.111395 · Cited by 11
Shen, F., Weng, S., Tsai, M., Su, Y., Li, S., Chang, S., Chen, J., Chang, Y., Liou, C., Lin, T., et al. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13629 · Cited by 11
de Carvalho, F. G., Muñoz, V. R., Brandão, C., Simabuco, F. M., Pavan, I. C. B., Nakandakari, S. C. B. R., Pauli, J. R., de Moura, L. P., Ropelle, E. R., Marchini, J. S., et al. (2021) · Nutrition · doi:10.1016/j.nut.2021.111430 · Cited by 11
Hanschkow, M., Boulet, N., Kempf, E., Bouloumié, A., Kieß, W., Stein, R., Körner, A., & Landgraf, K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab630 · Cited by 11
Pergola, G. D., Castellana, F., Zupo, R., Nucci, S. D., Panza, F., Castellana, M., Lampignano, L., Chito, M. D., Triggiani, V., Sardone, R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-03583-3 · Cited by 11
Kolefer, K., Miaffo, D., & Ponka, R. (2021) · The Scientific World JOURNAL · doi:10.1155/2021/1502230 · Cited by 11
Kaur, A., Ojo, B. A., Wong, S. Y., et al. (2021) · Nutrition Research · doi:10.1016/j.nutres.2021.10.003 · Cited by 11
Khezri, S., Alihemmati, A., & Abedelahi, A. (2021) · JBRA · doi:10.5935/1518-0557.20210089 · Cited by 11
Maternal mindful eating as a target for improving metabolic outcomes in pregnant women with obesity
Lindsay, K. L., Most, J., Buehler, K., Kebbe, M., Altazan, A. D., & Redman, L. M. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/5048 · Cited by 12
Glycemic Markers and Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA)
Echouffo-Tcheugui, J. B., Ogunmoroti, O., Golden, S. H., Bertoni, A. G., Mongraw‐Chaffin, M., Pandey, A., Ndumele, C. E., & Michos, E. D. (2022) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2022.01.011 · Cited by 11
Landete, P., Fernández-García, C. E., Orzaiz, B. A., Olivo, M. H., Acosta-Gutiérrez, C. M., Zamora-García, E., Ancochea, J., González‐Rodríguez, Á., & García‐Monzón, C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.808417 · Cited by 11
Zhou, F., Sun, X., Liu, J., Li, L., Li, L., & Li, P. (2022) · Endocrine · doi:10.1007/s12020-022-03014-x · Cited by 11
Chowdhary, A., Thirunavukarasu, S., Jex, N., Coles, L., Bowers, C., Sengupta, A., Swoboda, P., Witte, K., Cubbon, R., Xue, H., et al. (2022) · Obesity · doi:10.1002/oby.23413 · Cited by 10
Shin, Y., Moon, J. H., Oh, T. J., Ahn, C. H., Moon, J. H., Choi, S. H., & Jang, H. C. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0334 · Cited by 11
Saito, H., Kato, M., Yoshida, A., & Naito, M. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.erratum22681 · Cited by 11
Effect of excess weight and insulin resistance on DNA methylation in prepubertal children
Barbosa, P., Landes, R. D., Graw, S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-12325-y · Cited by 11
Farhadi‐Azar, M., Ghahremani, M., Mahboobifard, F., Noroozzadeh, M., Yaghmaei, P., & Tehrani, F. R. (2022) · Biomedical Journal · doi:10.1016/j.bj.2022.05.003 · Cited by 11
Lomzenski, H. E., Thiele, G. M., Duryee, M. J., Chen, S., Ye, F., Anderson, D. R., Mikuls, T. R., & Ormseth, M. J. (2022) · Scientific Reports · doi:10.1038/s41598-022-14954-9 · Cited by 11
Giannini, C., Polidori, N., Chiarelli, F., & Mohn, A. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01164-6 · Cited by 11
Rajendra, V. K. P., Kurapati, S., Balineni, S. K., & Gogineni, N. T. (2022) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v12i7.958 · Cited by 12
de Steenwinkel, F. D. O., Dolhain, R. J. E. M., Hazes, J. M. W., & Hokken-Koelega, A. (2022) · Clinical Rheumatology · doi:10.1007/s10067-022-06347-0 · Cited by 11
Zhou, X. J., Lin, X., Chen, J., Pu, J., Wu, W., Wu, Z., Lin, H., Huang, K., Zhang, L. R., Dai, Y.-L., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.986841 · Cited by 11
Nucci, S. D., Castellana, F., Zupo, R., Lampignano, L., Chito, M. D., Rinaldi, R., Giannuzzi, V., Cozzolongo, R., Piazzolla, G., Giannelli, G., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1002669 · Cited by 11
Moreira, F. D., Reis, C. E. G., Welker, A. F., & Gallassi, A. D. (2022) · Nutrients · doi:10.3390/nu14183736 · Cited by 11
Saito, I., Maruyama, K., Kato, T., Takata, Y., Tomooka, K., Kawamura, R., Osawa, H., & Tanigawa, T. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108319 · Cited by 11
Obesity is associated with a higher Torque Teno viral load compared to leanness
Herz, C. T., Kulterer, O. C., Kulifaj, D., Gelas, F., Franzke, B., Haupenthal, F., Prager, G., Langer, F. B., Marculescu, R., Haug, A. R., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.962090 · Cited by 11
Gorgey, A. S., Khalil, R. E., Alrubaye, M. W., Gill, R. S., Rivers, J. F., Goetz, L. L., Cifu, D. X., Castillo, T. A., Caruso, D. M., Lavis, T. D., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-064748 · Cited by 11
Tekoh, B. N., Samba, E. A. M., Etoga, M. C. E., Eko, M. A., Amazia, F., Agoons, B. B., Nansseu, J. R., Bigna, J. J., & Ama-Moor, V. J. (2022) · BMC Research Notes · doi:10.1186/s13104-022-06214-w · Cited by 11
Gasco, V., Giannelli, J., Campioni, L., Arvat, E., Ghigo, E., Grottoli, S., Maccario, M., & Giordano, R. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01940-1 · Cited by 11
Metabolomic markers of glucose regulation after a lifestyle intervention in prediabetes
Sevilla-González, M. D. R., Manning, A. K., Westerman, K. E., Aguilar-Salinas, C. A., Deik, A., & Clish, C. B. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003010 · Cited by 11
Dietrich, J. W., Dasgupta, R., Shajith Anoop, S., Jebasingh, F., Kurian, M. E., Inbakumari, M., Boehm, B. O., & Thomas, N. (2022) · Scientific Reports · doi:10.1038/s41598-022-22531-3 · Cited by 12
Mishra, I., Pradhan, J., Rattan, R., Choudhury, A. K., & Baliarsinha, A. K. (2022) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_104_22 · Cited by 11
Kang, N., Song, X., Zhang, C., Li, R., Yuchi, Y., Liao, W., Hou, X., Liu, X., Mao, Z., Huo, W., et al. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114283 · Cited by 12
Ranathunga, I., Athukorala, T. G., Sumanatilleke, M., & Somasundaram, N. P. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01206-0 · Cited by 13
Berezin, A. A., Obradovic, Z., Novikov, E. V., Boxhammer, E., Lichtenauer, M., & Berezin, A. Е. (2022) · Diagnostics · doi:10.3390/diagnostics12122940 · Cited by 12
Lin, C.-A., Li, W.-C., Lin, S., et al. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00956-0 · Cited by 11
Teixeira, B. S., Silva, C. M., Silva, A. T. F., Santos, L. L. D., Maia, Y. C. D. P., Pedrazzoli, M., Wright, K. P., & Crispim, C. A. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-03069-6 · Cited by 14
Wang, J., Campos, A. I., García‐Marín, L. M., Rentería, M. E., & Xu, L. (2023) · Obesity · doi:10.1002/oby.23669 · Cited by 10
Hartmann, H., Janssen, L. K., Herzog, N., Morys, F., Fängström, D., Fallon, S. J., & Horstmann, A. (2023) · Appetite · doi:10.1016/j.appet.2023.106477 · Cited by 11
Cheong, J. L. Y., Olsen, J. E., Konstan, T., Mainzer, R., Hickey, L. M., Spittle, A. J., Wark, J. D., Cheung, M. M. H., Garland, S. M., Duff, J., et al. (2023) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2023.100717 · Cited by 11
Reljic, D., Frenk, F., Herrmann, H. J., Neurath, M. F., & Zopf, Y. (2023) · Healthcare · doi:10.3390/healthcare11050711 · Cited by 14
Kang, S. M., Yun, H. M., Sohn, M., & Lim, S. K. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15056 · Cited by 11
Lisowska, A., Dubatówka, M., Chlabicz, M., Jamiołkowski, J., Kondraciuk, M., Szyszkowska, A. M., Knapp, M., Szpakowicz, A., Łukasiewicz, A., & Kamiński, K. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072627 · Cited by 13
El‐Khateeb, E., Elberri, E. I., Mosalam, E. M., Nooh, M. Z., Abdelsattar, S., Alghamdi, A. M., Alrubia, S., & Abdallah, M. S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1153653 · Cited by 11
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
